Latest filing published 07 Mar 2023 for Jazz Pharmaceuticals plc.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Finbar Larkin: trading record in brief
Finbar Larkin is a declared insider of Jazz Pharmaceuticals plc (senior executive), with filings sourced from SEC (Form 4). In total, 19 filings cover trades dated from 7 November 2019 to 7 March 2023.
Every open-market trade on record is a sale: 13 sales worth €1.2M. Outside the open market, there are 5 share grants and 1 option exercise. 2023 to date brings no purchases and 2 sales.
The latest filing, published on 7 March 2023, reports an option exercise of €94k in Jazz Pharmaceuticals plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Finbar Larkin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,373 shares0Ordinary SharesSEC:0001765581-23-000032:0
- 197 shares@ US$149.338.2% of flowOrdinary SharesSEC:0001765581-22-000122:0
- 63 shares@ US$150.002.7% of flowOrdinary SharesSEC:0001765581-22-000114:0
- 1,747 shares@ US$148.936978.2% of flowOrdinary SharesSEC:0001765581-22-000049:0
- 4,621 shares0Ordinary SharesSEC:0001765581-22-000021:0
- 197 shares@ US$135.797.4% of flowOrdinary SharesSEC:0001765581-21-000127:0
- 63 shares@ US$134.512.3% of flowOrdinary SharesSEC:0001765581-21-000118:0
7 of 7 declarations
